Business
Trials of AstraZeneca COVID vaccine resuming after ‘wake up call’ – Sydney Morning Herald
British clinical trials for the AstraZeneca and Oxford University coronavirus vaccine have resumed following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so, the company said on Saturday.
The patient involved in the study had been reportedly suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.
AstraZeneca, based in Cambridge, said it could not disclose further medical information.
“The company will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic,” AstraZeneca said.
It …
-
General26 mins agoFerries and celebrities as pollies dash to win the west
-
Noosa News20 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
General21 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Noosa News23 hours agoVHM’s Goschen Rare Earths and Mineral Sands Project granted 20-year licence